Zobrazeno 1 - 10
of 172
pro vyhledávání: '"Ulrich, Speck"'
Autor:
Ulrich Speck
This open access book is an overview on CT/X-ray contrast media designed for radiologists and other medical specialists who use contrast media in imaging and interventional procedures as well as related scientists on the use and pharmaceutical aspect
Autor:
Tobias Haase, Ulrich Speck, Stephanie Bienek, Melanie Löchel, Nadia Brunacci, Ole Gemeinhardt, Denise Schütt, Stephanie Bettink, Bettina Kelsch, Bruno Scheller, Beatrix Schnorr
Publikováno v:
Frontiers in Bioscience-Landmark, Vol 27, Iss 10, p 283 (2022)
Background: Although controversially discussed, paclitaxel is the only clinically proven drug that inhibits restenosis when released from drug-coated balloons (DCBs). Limus drugs are currently being explored as alternatives. The aim of the preclinica
Externí odkaz:
https://doaj.org/article/0e4240f35d2f40668d185846f179c576
Publikováno v:
PLoS ONE, Vol 16, Iss 10 (2021)
Background Drug coated balloons (DCB) with paclitaxel (Ptx) dose of 2–3.5 μg/mm2 balloon surface inhibit restenosis with different effectiveness and duration of success. A clinical dose finding study is not known for any of the currently marketed
Externí odkaz:
https://doaj.org/article/4d8ee17b77ac461ca4a5163a6fc3ea4c
Autor:
Philipp von Gottberg, Alexandru Cimpoca, Christina Wendl, José E. Cohen, Ulrich Speck, Hans Henkes
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 23, Iss 4, p 128 (2022)
Background: Drug-coated balloons (DCB) are an established tool in the prevention and treatment of coronary and peripheral artery restenosis. The underlying effects of restenosis resemble those in the neurovascular field, yet data on the use of DCB in
Externí odkaz:
https://doaj.org/article/350b426752ce40fe94092f340f44855b
Autor:
Ole Gemeinhardt, Tobias Haase, Beatrix Schnorr, Jing Xie, Melanie Löchel, Denise Schütt, Antje Mittag, Wolfram Haider, Stephanie Bettink, Ulrich Speck, Gunnar Tepe
Publikováno v:
Cardiovascular and interventional radiology. 45(12)
Purpose Clinical data indicate that the drug density on drug-coated balloons (DCBs) might have a role on treatment effect and durability. The aim of the current study was to investigate inhibition of neointimal formation and potential adverse effects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6c555f4dbbc8451ee32063c7ef631a1
https://pubmed.ncbi.nlm.nih.gov/36316493
https://pubmed.ncbi.nlm.nih.gov/36316493
Autor:
Beatrix Schnorr, Bruno Scheller, Bettina Kelsch, Stephanie Bettink, Denise Schütt, Ole Gemeinhardt, Nadia Brunacci, Melanie Löchel, Stephanie Bienek, Ulrich Speck, Tobias Haase
Publikováno v:
Frontiers in bioscience (Landmark edition). 27(10)
Although controversially discussed, paclitaxel is the only clinically proven drug that inhibits restenosis when released from drug-coated balloons (DCBs). Limus drugs are currently being explored as alternatives. The aim of the preclinical studies wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ee79f9d4734c99d1f5235c3a92319c5
https://pubmed.ncbi.nlm.nih.gov/36336862
https://pubmed.ncbi.nlm.nih.gov/36336862
Autor:
Peter Reimer, Gunnar Tepe, Ulrich Speck, Thomas Zeller, Klaus Brechtel, Jean-Luc Baeriswyl, Nicolas Diehm, Thomas Albrecht, Henrik Schroeder
Publikováno v:
Journal of Endovascular Therapy. 27:276-286
Purpose: To investigate the efficacy and sustainability of drug-coated balloon (DCB) treatment of femoropopliteal in-stent restenosis (ISR). Materials and Methods: An investigator-initiated, prospective, multicenter, 1:1 randomized study enrolled 88
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cd76360d7700cdc1abb397101fb5bdb
https://doi.org/10.1177/1526602820907917
https://doi.org/10.1177/1526602820907917
Autor:
Thomas, Albrecht, Antonia, Ukrow, Michael, Werk, Gunnar, Tepe, Thomas, Zeller, Dirk-Roelfs, Meyer, Maren, Kutschera, Ulrich, Speck, Matthias, Waliszewski
Publikováno v:
CardioVascular and Interventional Radiology. 42:495-504
The principal objective of this pooled analysis was to investigate various patient and lesion characteristics on late lumen loss (LLL) after drug-coated balloon (DCB) angioplasty.Four randomized controlled trials (THUNDER, FEMPAC, PACIFIER, CONSEQUEN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2248d19b242736eeedd1f3bcc7706395
https://doi.org/10.1007/s00270-018-2137-3
https://doi.org/10.1007/s00270-018-2137-3
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 10 (2021)
PLoS ONE, Vol 16, Iss 10, p e0259106 (2021)
PLoS ONE, Vol 16, Iss 10 (2021)
PLoS ONE, Vol 16, Iss 10, p e0259106 (2021)
Background Drug coated balloons (DCB) with paclitaxel (Ptx) dose of 2–3.5 μg/mm2 balloon surface inhibit restenosis with different effectiveness and duration of success. A clinical dose finding study is not known for any of the currently marketed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bae1f3a9f000ced8c778edf82efc52b0
https://pubmed.ncbi.nlm.nih.gov/34714843
https://pubmed.ncbi.nlm.nih.gov/34714843
Autor:
Hans Henkes, Ulrich Speck, José E. Cohen, Christina Wendl, Alexandru Cimpoca, Philipp von Gottberg
Publikováno v:
Reviews in Cardiovascular Medicine. 23:128
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14b92c1d1744573994080000cec62793
https://doi.org/10.31083/j.rcm2304128
https://doi.org/10.31083/j.rcm2304128